POINT Biopharma Global Inc.
World Rank (Aug-2026)
8,923
World Rank (Jan-05-2024)
8,923
World Rank (Jul-30-2023)
8,923
Market Cap (Jul-30-2023)
0.962 Billion USD
World Rank (Dec-25-2022)
10,135
Market Cap (Dec-25-2022)
0.727 Billion USD
World Rank (Jan-07-2022)
13,170
Market Cap (Jan-07-2022)
0.52 Billion USD
Annual Revenue in USD
226 Million USD
Annual Net Income in USD
98 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Company Profile
POINT Biopharma Global Inc. is a Clinical Stage Global Pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer. The headquarters is in USA.
Company Website